Abstract

Á Rebollo-Román1*, S Merino-Molina2, AD Herrera-Martínez1, C Muñoz-Jiménez1, JF Ruiz- Rabelo3 and MJ Molina-Puerta1 Author Affiliations 1Department of Endocrinology and Nutrition at Maimonides Biomedical Research Institute, University Hospital Reina Sofía, Córdoba University, Spain 2Department of Dermatology, University Hospital Virgen de la Victoria, Málaga, Spain 3Department of Surgery, Endocrine Surgery Division, University Hospital Reina Sofía, Córdoba University, Spain Received: July 03, 2021 | Published: July 15, 2021 Corresponding author: Ángel Rebollo Román, Department of Endocrinology and Nutrition at Maimonides Biomedical Research Institute. University Hospital “Reina Sofía”. Córdoba University, Spain DOI: 10.26717/BJSTR.2021.37.005970

Highlights

  • Obesity has become one of the most important health problems in our society

  • The part evaluating the postoperative evolution is divided into two sections: weight loss evaluated as the percent excess weight loss (%Excess Weight Loss (EWL)) and the resolution of comorbidities

  • Of patients suffered from DM2 (n=48); 40.8% from high blood pressure (HBP) (n=62); 35.5% from dyslipidemia (n= 54); 19.7% from obstructive sleep apnea (OSA) (n=30); 11,8% from arthropathy (n= 18) and 4.6% patients (n=7) had suffered a cardiovascular event

Read more

Summary

Introduction

Obesity has become one of the most important health problems in our society. Obesity accounts for 44% of diabetes type 2 (DM2) and nonalcoholic steatohepatitis (NASH) affects practically every obese patient. This excess weight is the main risk factor for obstructive sleep apnea (OSA). Obesity is a preventable cause of diverse cancer types: colon, rectum, breast, uterus, kidney, esophagus and pancreas [3] It impacts the personal sphere with a reduced functionality in the everyday life activities and a worse quality of life (QoL). Anxiety and depression are very frequent symptoms The prevalence of the latter ranges from 23 to 69% much higher than the in the general population (17%). Obesity is a well-known risk factor for type 2 diabetes (DM2), obstructive sleep apnea (OSA) and cardiovascular illnesses and it entails a worse quality of life (QoL)

Objectives
Methods
Results
Discussion
Conclusion
Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.